Charitable trust registration requires a specified-violation notice; settled cash deposits and related-party payments did not justify cancellation or ...
External development charges trigger TDS under section 194C, while disputed administrative payments require factual verification and fresh adjudicatio...
Section 270AA penalty immunity requires identified statutory defaults and a hearing before rejection; reassessment disclosure may constitute under-rep...
Section 80JJAA employee-cost deduction allowed for deployed staff but barred against transfer-pricing income enhancement, with pricing issues remanded...
Transfer-pricing methodology protects commercially genuine associated-enterprise payments, while pre-2016 secondary adjustments and related notional i...
Negative liens over operating assets can constitute international transactions requiring arm's-length pricing reflecting restricted borrowing and expa...
Cross-examination rights in Customs Broker revocation inquiries require witness examination; procedural denial may be cured through fresh adjudication...
The appellant performed clinical study services in India on drugs supplied by their foreign client and delivered the clinical study report through email, courier, or website. The department argued that since the service was performed in India on goods supplied by the recipient, it did not qualify as export of service u/r 4 of the Place of Provision of Service Rules, 2012. However, relying on previous judgments in Sai Life Sciences Ltd. and Fertin Pharma Research & Development India Pvt. Ltd., it was held that conducting clinical trials on drugs supplied by a foreign service recipient and providing the technical report constitutes export of service u/r 3 of the Rules, 2012. Therefore, such services are not liable to service tax. The impugned order was set aside, and the appeal was allowed.
The appellant performed clinical study services in India on drugs supplied by their foreign client and delivered the clinical study report through email, courier, or website. The department argued that since the service was performed in India on goods supplied by the recipient, it did not qualify as export of service u/r 4 of the Place of Provision of Service Rules, 2012. However, relying on previous judgments in Sai Life Sciences Ltd. and Fertin Pharma Research & Development India Pvt. Ltd., it was held that conducting clinical trials on drugs supplied by a foreign service recipient and providing the technical report constitutes export of service u/r 3 of the Rules, 2012. Therefore, such services are not liable to service tax. The impugned order was set aside, and the appeal was allowed.
Note: It is a system-generated summary and is for quick reference only.